Irobot Financials
This page shows Irobot (IRBT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Irobot has an operating margin of -15.1%, meaning the company retains $-15 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -29.6% the prior year.
Irobot's revenue declined 23.4% year-over-year, from $890.6M to $681.8M. This contraction results in a growth score of 0/100.
Irobot has elevated debt relative to equity (D/E of 7.43), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
Irobot's current ratio of 1.32 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.
While Irobot generated -$33.2M in operating cash flow, capex of $118K consumed most of it, leaving -$33.3M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Irobot passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Irobot generates $0.23 in operating cash flow (-$33.2M OCF vs -$145.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Irobot earns $-4.8 in operating income for every $1 of interest expense (-$103.0M vs $21.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Irobot generated $681.8M in revenue in fiscal year 2024. This represents a decrease of 23.4% from the prior year.
Irobot's EBITDA was -$81.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 64.9% from the prior year.
Irobot generated -$33.3M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 71.7% from the prior year.
Irobot reported -$145.5M in net income in fiscal year 2024. This represents an increase of 52.2% from the prior year.
Irobot earned $-4.92 per diluted share (EPS) in fiscal year 2024. This represents an increase of 55.3% from the prior year.
Irobot held $134.3M in cash against $0 in long-term debt as of fiscal year 2024.
Irobot had 31M shares outstanding in fiscal year 2024. This represents an increase of 9.5% from the prior year.
Irobot's gross margin was 20.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 1.2 percentage points from the prior year.
Irobot's operating margin was -15.1% in fiscal year 2024, reflecting core business profitability. This is up 14.5 percentage points from the prior year.
Irobot's net profit margin was -21.3% in fiscal year 2024, showing the share of revenue converted to profit. This is up 12.9 percentage points from the prior year.
Irobot invested $93.3M in research and development in fiscal year 2024. This represents a decrease of 35.0% from the prior year.
Irobot invested $118K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 95.9% from the prior year.
IRBT Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $145.8M+14.3% | $127.6M+25.6% | $101.6M-41.0% | $172.0M+3.4% | $166.4M+10.9% | $150.0M-51.2% | $307.5M+65.2% | $186.2M |
| Cost of Revenue | $100.6M+12.7% | $89.3M+9.8% | $81.3M-47.8% | $155.6M+12.0% | $138.9M+21.9% | $113.9M-54.3% | $249.4M+80.5% | $138.2M |
| Gross Profit | $45.3M+18.2% | $38.3M+88.5% | $20.3M+23.8% | $16.4M-40.2% | $27.5M-23.9% | $36.1M-37.9% | $58.1M+21.1% | $48.0M |
| R&D Expenses | $13.1M-4.9% | $13.8M-6.3% | $14.7M-11.2% | $16.5M-28.8% | $23.2M-31.4% | $33.9M+25.7% | $26.9M-27.8% | $37.3M |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | $18.9M-33.3% | $28.4M |
| Operating Income | -$17.7M+51.9% | -$36.7M+19.7% | -$45.8M+25.0% | -$61.0M0.0% | -$61.1M-613.2% | $11.9M+122.8% | -$52.2M+12.2% | -$59.5M |
| Interest Expense | $1.6M-68.6% | $5.1M+2.0% | $5.0M-3.8% | $5.2M-3.7% | $5.4M-1.8% | $5.5M | N/A | N/A |
| Income Tax | $3.1M+701.1% | -$523K-214.4% | $457K+129.7% | -$1.5M-311.1% | $729K+575.0% | $108K-98.4% | $6.6M+1004.0% | $598K |
| Net Income | -$21.5M+5.6% | -$22.8M+73.9% | -$87.3M-13.2% | -$77.1M-9.1% | -$70.6M-920.8% | $8.6M+113.5% | -$63.6M+19.7% | -$79.2M |
| EPS (Diluted) | $-0.62+8.8% | $-0.68+76.1% | $-2.84-9.2% | $-2.60-7.9% | $-2.41-903.3% | $0.30+113.2% | $-2.27+20.6% | $-2.86 |
IRBT Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $481.6M+0.3% | $480.3M+4.1% | $461.5M-10.6% | $516.1M-11.9% | $585.9M-6.4% | $626.1M-14.7% | $733.7M-11.8% | $831.5M |
| Current Assets | $248.5M+1.5% | $244.8M+4.5% | $234.3M-18.8% | $288.5M-15.2% | $340.1M-8.5% | $371.9M-20.1% | $465.5M-16.4% | $556.8M |
| Cash & Equivalents | $24.8M-38.8% | $40.6M-41.9% | $69.9M-47.9% | $134.3M+23.8% | $108.5M-8.3% | $118.4M-36.1% | $185.1M-2.4% | $189.6M |
| Inventory | $140.9M+59.7% | $88.2M+27.9% | $69.0M-9.3% | $76.0M-25.0% | $101.4M-24.0% | $133.3M-12.6% | $152.5M-37.6% | $244.5M |
| Accounts Receivable | $56.8M+1.3% | $56.1M+82.0% | $30.8M-38.2% | $49.9M-26.8% | $68.1M+73.3% | $39.3M-50.5% | $79.4M+8.1% | $73.5M |
| Goodwill | $182.4M0.0% | $182.4M+6.4% | $171.5M+2.5% | $167.3M-1.2% | $169.4M-0.2% | $169.7M-3.1% | $175.1M+4.5% | $167.6M |
| Total Liabilities | $508.5M+4.2% | $488.0M+5.6% | $462.3M+1.6% | $454.9M+4.1% | $436.9M+3.5% | $422.1M-21.4% | $537.2M-7.2% | $578.6M |
| Current Liabilities | $480.9M+5.3% | $456.6M+6.7% | $427.9M+96.1% | $218.2M-1.5% | $221.6M+6.9% | $207.4M-27.8% | $287.1M-11.8% | $325.4M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$26.9M-249.5% | -$7.7M-870.0% | -$793K-101.3% | $61.2M-58.9% | $149.1M-26.9% | $204.1M+3.9% | $196.5M-22.3% | $252.9M |
| Retained Earnings | -$382.4M-6.0% | -$360.9M-6.7% | -$338.1M-34.8% | -$250.8M-49.9% | -$167.3M-73.1% | -$96.7M+8.2% | -$105.3M-152.5% | -$41.7M |
IRBT Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$47.6M-57.8% | -$30.2M-14.0% | -$26.5M-863.6% | -$2.7M+87.3% | -$21.7M-1608.0% | $1.4M+224.3% | -$1.2M+97.9% | -$55.5M |
| Capital Expenditures | $0 | $0 | $0 | $0 | $0-100.0% | $118K+143.7% | -$270K-143.7% | $618K |
| Free Cash Flow | -$47.6M-57.8% | -$30.2M-14.0% | -$26.5M-863.6% | -$2.7M+87.3% | -$21.7M-1742.9% | $1.3M+192.5% | -$1.4M+97.5% | -$56.1M |
| Investing Cash Flow | $594K+10000.0% | -$6K+25.0% | -$8K+90.0% | -$80K-73.9% | -$46K+61.0% | -$118K-147.2% | $250K+137.1% | -$673K |
| Financing Cash Flow | -$114K+97.3% | -$4.2M-4867.9% | -$84K+36.4% | -$132K-101.1% | $12.0M+140.1% | -$29.9M-3310.5% | -$878K-100.5% | $188.1M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
IRBT Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.0%+1.0pp | 30.0%+10.0pp | 20.0%+10.5pp | 9.5%-7.0pp | 16.5%-7.6pp | 24.1%+5.2pp | 18.9%-6.9pp | 25.8% |
| Operating Margin | -12.1%+16.7pp | -28.8%+16.3pp | -45.0%-9.6pp | -35.5%+1.2pp | -36.7%-44.6pp | 7.9%+24.9pp | -17.0%+15.0pp | -32.0% |
| Net Margin | -14.8%+3.1pp | -17.9%+68.0pp | -85.9%-41.1pp | -44.8%-2.3pp | -42.5%-48.2pp | 5.7%+26.4pp | -20.7%+21.9pp | -42.5% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | 4.2% | N/A | N/A |
| Return on Assets | -4.5%+0.3pp | -4.8%+14.2pp | -18.9%-4.0pp | -14.9%-2.9pp | -12.1%-13.4pp | 1.4%+10.0pp | -8.7%+0.9pp | -9.5% |
| Current Ratio | 0.52-0.0 | 0.54-0.0 | 0.55-0.8 | 1.32-0.2 | 1.53-0.3 | 1.79+0.2 | 1.62-0.1 | 1.71 |
| Debt-to-Equity | -18.91+44.5 | -63.44+519.5 | -582.98-590.4 | 7.43+4.5 | 2.93+0.9 | 2.07-0.7 | 2.73+0.4 | 2.29 |
| FCF Margin | -32.6%-9.0pp | -23.6%+2.4pp | -26.1%-24.4pp | -1.6%+11.4pp | -13.0%-13.9pp | 0.9%+1.3pp | -0.5%+29.7pp | -30.2% |
Similar Companies
Frequently Asked Questions
What is Irobot's annual revenue?
Irobot (IRBT) reported $681.8M in total revenue for fiscal year 2024. This represents a -23.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Irobot's revenue growing?
Irobot (IRBT) revenue declined by 23.4% year-over-year, from $890.6M to $681.8M in fiscal year 2024.
Is Irobot profitable?
No, Irobot (IRBT) reported a net income of -$145.5M in fiscal year 2024, with a net profit margin of -21.3%.
What is Irobot's earnings per share (EPS)?
Irobot (IRBT) reported diluted earnings per share of $-4.92 for fiscal year 2024. This represents a 55.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Irobot's EBITDA?
Irobot (IRBT) had EBITDA of -$81.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Irobot's gross margin?
Irobot (IRBT) had a gross margin of 20.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Irobot's operating margin?
Irobot (IRBT) had an operating margin of -15.1% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Irobot's net profit margin?
Irobot (IRBT) had a net profit margin of -21.3% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Irobot's free cash flow?
Irobot (IRBT) generated -$33.3M in free cash flow during fiscal year 2024. This represents a 71.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Irobot's operating cash flow?
Irobot (IRBT) generated -$33.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Irobot's total assets?
Irobot (IRBT) had $516.1M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Irobot's capital expenditures?
Irobot (IRBT) invested $118K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Irobot spend on research and development?
Irobot (IRBT) invested $93.3M in research and development during fiscal year 2024.
How many shares does Irobot have outstanding?
Irobot (IRBT) had 31M shares outstanding as of fiscal year 2024.
What is Irobot's current ratio?
Irobot (IRBT) had a current ratio of 1.32 as of fiscal year 2024, which is considered adequate.
What is Irobot's debt-to-equity ratio?
Irobot (IRBT) had a debt-to-equity ratio of 7.43 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Irobot's return on assets (ROA)?
Irobot (IRBT) had a return on assets of -28.2% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Irobot's cash runway?
Based on fiscal year 2024 data, Irobot (IRBT) had $134.3M in cash against an annual operating cash burn of $33.2M. This gives an estimated cash runway of approximately 49 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Irobot's Piotroski F-Score?
Irobot (IRBT) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Irobot's earnings high quality?
Irobot (IRBT) has an earnings quality ratio of 0.23x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Irobot cover its interest payments?
Irobot (IRBT) has an interest coverage ratio of -4.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Irobot?
Irobot (IRBT) scores 7 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.